+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A case of diffuse and hematogenous pulmonary metastatic malignant pleural mesothelioma with increased CYFRA in the pleural effusion and in the serum



A case of diffuse and hematogenous pulmonary metastatic malignant pleural mesothelioma with increased CYFRA in the pleural effusion and in the serum



Nihon Naika Gakkai Zasshi 87(10): 2084-2085




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062672615

Download citation: RISBibTeXText

DOI: 10.2169/naika.87.2084


Related references

A case of diffuse pulmonary metastasis of malignant pleural mesothelioma with elevated CYFRA in serum and pleural effusion. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 87(10): 2084-2085, 1998

A case of malignant pleural mesothelioma with elevation of G-CSF and CYFRA in the serum and pleural fluid. Nihon Kokyuki Gakkai Zasshi 45(3): 243-247, 2007

49P Accuracy of pleural fluid cytology in patients with malignant pleural effusion from non-small-cell lung cancer, pulmonary metastases and pleural mesothelioma. A case-control study. Journal of Thoracic Oncology 11(4 Suppl.): S75-S75, 2016

Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion. European Journal of Radiology 85(9): 1594-1600, 2016

Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology. Anticancer Research 34(12): 7425-7429, 2014

Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases. Lung 172(3): 183-184, 1994

Pleuro-pneumonectomy in the treatment of pulmonary carcinoma complicated with diffuse pleural metastasis and malignant pleural effusion. Zhongguo Fei Ai Za Zhi 8(5): 465-467, 2005

An autopsy case of diffuse malignant mesothelioma with markedly elevated lactic dehydrogenase level in pleural effusion. Japanese Journal of Chest Diseases 41(4): 345-349, 1982

P2.07-059 Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (Gmci) for Malignant Pleural Effusion (Mpe) and Malignant Pleural Mesothelioma (Mpm). Journal of Thoracic Oncology 12(11): S2151-S2152, 2017

The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion. Indian Journal of Cancer 51(Suppl. 3): E82-E85, 2014

The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion. Contemporary Oncology 21(3): 213-217, 2017

Pleural effusion hyaluronic acid as a prognostic marker in pleural malignant mesothelioma. Lung Cancer 82(3): 491-498, 2013

Fibronectin is unsuitable as a tumor marker in pleural effusion due to malignant pleural mesothelioma. Chest 106(2 Suppl. ): 96S, 1994

Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma. Respiratory Medicine 105(1): 137-142, 2011

Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma. Oncology Letters 3(3): 581-585, 2012